Results 1 to 10 of about 412,640 (216)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults [PDF]

open access: yesVaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk   +7 more
doaj   +3 more sources

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship. [PDF]

open access: yesmBio, 2020
I have read the article by Fidel and Noverr with great interest (1). As told in the article, could measles-mumps-rubella (MMR) vaccine really be a “low-risk–high-reward” measure in COVID-19? However, I have several concerns about their opinion/hypothesis posed in their article (1).
Özdemir Ö.
europepmc   +4 more sources

Seroprevalence of IgG Antibodies to Measles, Mumps, Rubella and Varicella in Adolescents with Documented Two-Dose MMR Vaccination: Cross-Sectional Study [PDF]

open access: yesAntibodies
Background: Measles, mumps, and rubella outbreaks continue to occur despite high vaccination coverage, raising concerns about long-term vaccine-induced immunity. This study assessed serological protection against measles, mumps, rubella, and varicella in
Mikhail P. Kostinov   +9 more
doaj   +2 more sources

Waning Measles Immunity and Sustained Rubella Seroprotection Among Adults in Istanbul, Türkiye [PDF]

open access: yesMedicina
Background and Objectives: Despite long-standing MMR vaccination programmes, outbreaks of vaccine-preventable diseases continue to occur worldwide, raising concerns regarding waning immunity and susceptibility gaps in adult populations.
Kutay Sarsar   +4 more
doaj   +2 more sources

Completeness of MMR Vaccination and Durability of Vaccine-Induced Antibody Responses in Children with Inflammatory Bowel Disease [PDF]

open access: yesBiomedicines
Background: Children with IBD are at increased risk of suboptimal maintenance of vaccine-induced immunity, particularly when the MMR vaccination course is incomplete before diagnosis and initiation of immunosuppressive therapy. We conducted a prospective
Ivan S. Samolygo   +8 more
doaj   +2 more sources

Mumps resurgence despite MMR: Limitations of current vaccines and the need for new strategies [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
Mumps has reemerged globally despite widespread use of the measles – mumps – rubella (MMR) vaccine, contrasting with the successful control of measles and rubella.
Vipin M. Vashishtha, Unmesh Upadhyay
doaj   +2 more sources

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]

open access: yesScripta Medica, 2021
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj   +1 more source

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

open access: yesЭпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium   +9 more
doaj   +1 more source

Quality analysis of a combined domestic vaccine for the prevention of measles, rubella and mumps

open access: yesВопросы вирусологии, 2022
Introduction. The need to maintain a high level of vaccination coverage against measles, rubella and mumps in conditions of an increased risk of outbreaks of infections due to violations of vaccination tactics associated with the pandemic of coronavirus ...
Anna S. Binyatova   +5 more
doaj   +1 more source

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy